Browsing Category

38274 posts

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 and Chemotherapy as Adjuvant Treatment of Breast Cancer

SUZHOU, China, March 24, 2026 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) today…
ICP DAS-BMP Highlights Full Spectrum of Medical TPU Innovations at CMEF and Medtec Japan 2026

ICP DAS-BMP Highlights Full Spectrum of Medical TPU Innovations at CMEF and Medtec Japan 2026

HSINCHU, March 24, 2026 /PRNewswire/ — ICP DAS-BMP (Biomedical Polymers), a Taiwan-based…

Gen Z and Millennial High-Net-Worth Investors Are Reshaping Wealth Advice

CFA Institute survey of investors across global markets shows strong digital engagement,…

LEIFRAS Co., Ltd. Releases Two Business Introduction Videos Visualizing "Community Transfer of Club Activities" and "Sports Therapy"

Bringing to Life How Schools, Homes, and Communities Are Changing Across Japan…

Inspira Enterprise Joins the Microsoft Intelligent Security Association

MUMBAI, India, March 24, 2026 /PRNewswire/ — Inspira Enterprise, a global cybersecurity…

GTN completes Asia-Pacific "dual-hub" strategy with Hong Kong SFC licence

Second regulated entity in Asia connects global firms to US$3 trillion in…

The Phase 3 Registration STAR Study of Efdamrofusp Alfa (IBI302) Met its Primary Endpoint, Making it the First Self-developed Extended-interval Treatment for nAMD in China

73% of participants achieved Q16W dosing interval; Furthermore, nearly 60% of the…
WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus

WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus

TOMASZÓW MAZOWIECKI, Poland, March 24, 2026 /PRNewswire/ — A new hyperscale data center…